Early diagnosis in Parkinson’s disease — limitation of biochemical markers and instrumental methods
For most cases of Parkinson’s disease (PD) we can estimate the time lag from the first onset of unspecific complaints until diagnosis by case history to be about 2 years. Until now the exact course of neurodegeneration in PD is still unknown. On base of recent knowledge we can discuss different models for the development of PD. There are substantially different possible approaches to recognise PD as soon as possible. The time interval for an earlier diagnosis is different for these methods and depends on the real course of neurodegeration.
KeywordsStriatal Dopamine Instrumental Method Environmental Insult Motor Performance Test European Neurological Society
Unable to display preview. Download preview PDF.
- Gerlach M, Riederer P (1992) Gibt es biochemische Marker der Parkinson-Krankheit? In: Fischer PA (Hrsg) Parkinson-Krankheit: verlaufsbezogene Diagnostik und Therapie. Editiones <Roche>, Basel/Grenzach-WyhlenGoogle Scholar
- Koller W, Langston JW (eds) (1991) Preclinical detection of Parkinson’s disease. Neurology 41(5) [SuppI2]Google Scholar
- Leenders KL (1995) Oral presentation. Fifth meeting of the European Neurological SocietyGoogle Scholar
- Przuntek H, Riederer P (eds) (1989) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien New York (Key Topics in Brain Research)Google Scholar
- Segawa M, Nomura Y, Kase M (1986) Hereditary progressive Dystonia with marked diurnal fluctuation: clinicopathophysiological identification in reference to juvenile Parkinson’s disease. Adv Neurol 45: 227–234Google Scholar
- Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson’s disease. Ann Neurol 38(4): 589–598PubMedCrossRefGoogle Scholar